Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 8581
116th Congress(2019-2020)
Triple A Study Act
Introduced
Introduced
Introduced in House on Oct 13, 2020
Overview
Text
Introduced in House 
Oct 13, 2020
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Oct 13, 2020)
Oct 13, 2020
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 8581 (Introduced-in-House)


116th CONGRESS
2d Session
H. R. 8581


To direct the Government Accountability Office to evaluate appropriate coverage of assistive technologies provided to patients who experience amputation or live with limb difference.

IN THE HOUSE OF REPRESENTATIVES

October 13, 2020

Mr. Butterfield (for himself and Mr. Guthrie) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To direct the Government Accountability Office to evaluate appropriate coverage of assistive technologies provided to patients who experience amputation or live with limb difference.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Access to Assistive Technology and Devices for Americans Study Act” or the “Triple A Study Act”.

SEC. 2. Appropriate coverage of assistive technologies.

(a) In general.—Not later than 18 months after the date of enactment of this Act, the Comptroller General of the United States shall evaluate, and submit to Congress a report on such evaluation, the appropriate coverage, through insurance or otherwise, of assistive technologies provided to patients who experience amputation or live with limb difference, particularly prosthetic devices and custom orthoses, including—

(1) timely access to care, including educating patients regarding options for assistive technologies;

(2) assessments and guidelines for assistive device determinations;

(3) matching specific assistive devices with the needs of the individual beneficiary, such as women;

(4) the affordability of assistive devices;

(5) the provision of rehabilitation services to support acclimation to assistive devices; and

(6) appropriate timelines for assessments for surgery and assessments of assistive devices.

(b) Comparison of certain data.—As part of the evaluation conducted under subsection (a), the Comptroller General shall compare data on practices and outcomes derived from the Medicare program under title XVIII of the Social Security Act (42 U.S.C. 1395 et seq.), the Department of Veterans Affairs, and the commercial health insurance market relating to the coverage of assistive technologies, including—

(1) the percentage of patients who get access to assistive devices;

(2) performance measures that monitor the timeliness of processing prosthetic prescriptions;

(3) coverage denials and overturn rates;

(4) coding for physician or physical therapy assessments, including whether a prosthetist was engaged in the assessment;

(5) the rate of patients returning to work in general, and after receiving a prosthetic device comparable to other assistive technologies;

(6) reductions in long-term assistive technology services and supports;

(7) with respect to those using assistive technologies, policies to reduce falls and secondary complications, such as diabetes, heart disease, vascular disease, and others; and

(8) the amount expended by individual entities on prosthetics relative to total amount expended by such entities.